Assignee: Baker Norton Pharmaceuticals, Inc.

Location: Miami, FL
No. of patents: 24

Number	Title	Issue Date
7056898	Hypersulfated disaccharides and methods of using the same for the treatment of inflammations Provided are compounds and compositions thereof that are useful for treating inflammation, particularly pulmonary inflammations including asthma and asthma-related pathologies such as allergy. Also provided are methods for using such compounds and compositions of th...	06/06/2006
7041640	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), com...	05/09/2006
6964946	Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same Pharmaceutical compositions for oral administration to mammalian subjects comprise a taxane or taxane derivative (e.g., paclitaxel or docetaxel) as active ingredient and a vehicle comprising at least 30% by weight of a carrier for the taxane, said carrier having an ...	11/15/2005
6936583	Method and compositions for administering taxanes orally to human patients Taxane antineoplastic agents which have heretofore exhibited poor or non-existent oral bioavailability are administered orally to human patients suffering from taxane-responsive disease conditions and made sufficiently bioavailable to achieve therapeutic blood level...	08/30/2005
6818615	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), com...	11/16/2004
6730698	Method and compositions for administering taxanes orally to human patients Taxane antineoplastic agents which have heretofore exhibited poor or non-existent oral bioavailability are administered orally to human patients suffering from taxane-responsive disease conditions and made sufficiently bioavailable to achieve therapeutic blood level...	05/04/2004
6610735	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etop...	08/26/2003
6451285	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant Provided are pressurized metered dose inhalers containing stable formulations of a ଲ-agonist drug in suspension or solution. Also provided are aerosol formulations suitable for inhalation therapy containing a ଲ-agonist drug in suspension or so...	09/17/2002
6395770	Method and compositions for administering taxanes orally to human patients Taxane antineoplastic agents which have heretofore exhibited poor or non-existent oral bioavailability are administered orally to human patients suffering from taxane-responsive disease conditions and made sufficiently bioavailable to achieve therapeutic ...	05/28/2002
6334445	Methods and compositions for treatment of ovarian cancer Compositions and methods are provided which are effective in treating ovarian cancer. These compositions are easily administered by long term infusion schedules of at least 72 hours, and can be given in dosages that are safe and provide for manageable sid...	01/01/2002
6290930	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide Provided is a solution aerosol formulation adapted for use in a pressurized aerosol container. The aerosol formulation is formulated from a composition containing Budesonide, at least one fluoroalkane propellant, and a cosolvent present in an amount that ...	09/18/2001
6284800	Methods and compositions for treatment of asthma The present invention comprises methods and compositions for the treatment of bronchorestrictive disorders, including asthma, in humans or animals. The methods and compositions are effective in treatment of inflammatory responses, such as those found in a...	09/04/2001
6245805	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etop...	06/12/2001
6235725	Methods and compositions for the prevention of tolerance to medications The present invention pertains to the identification of moieties and methods of using the same for preventing tolerance to bronchodilators. More specifically, the present invention pertains to the identification of compositions and methods which are capab...	05/22/2001
6193957	Pharmaceutical compositions for treating late phase allergic reactions and inflammatory diseases A method of treating a mammalian patient suffering from or prone to a condition characterized by late phase allergic reactions, airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctiv...	02/27/2001
6187745	Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus A method of preventing, reducing or reversing nephrotoxicity or renal dysfunction induced by administration of a cyclosporin or tacrolimus to a mammalian patient. The method comprises the co-administration to the patient, either before, together with or a...	02/13/2001
6056966	Method and compositions for treating impotence Pharmaceutical compositions in topical or parenteral form containing specific organic mono- or dinitrates, some of them novel compounds, are effective in treating male impotence and erectile dysfunction through topical or intracavernosal administration to...	05/02/2000
6004537	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol Provided is a solution aerosol formulation adapted for use in a pressurized aerosol container. The aerosol formulation is formulated from a composition containing Budesonide, Formoterol at least one fluoroalkane propellant, and a cosolvent present in an a...	12/21/1999
5980865	Method for treating late phase allergic reactions and inflammatory diseases A method of treating a mammalian patient suffering from or prone to a condition characterized by late phase allergic reactions, airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctiv...	11/09/1999
5968972	Method for increasing the oral bioactivity of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel or etoposide), com...	10/19/1999
5690910	Method for treating asthma A method of treating a patient suffering from antigen-induced asthma who has been challenged with an antigen, or providing chronic treatment to an asthma patient to reduce airway hyperresponsiveness, comprising intrabronchial administration to the patient...	11/25/1997
5643892	Method of treating chronic progressive vascular diseases A method of treating a mammalian patient suffering from a chronic progressive vascular disease (CPVD) characterized by scarring and/or fibrosis to halt the progress of the disease and cause resolution of already-formed scarring or fibrotic lesions. The me...	07/01/1997
5422125	Method and composition for treatment of insulin resistance syndromes A method of treating human or animal patients suffering from insulin resistance syndromes, particularly diabetes mellitus, by administering an effective amount of the compound magnesium vanadate. Daily dosage ranges are preferably from about 2 to about 60...	06/06/1995
5187163	Anti-viral compounds, dosage forms and methods Novel anti-viral compounds comprise phosphate-linked dimers of anti-viral nucleoside derivatives, or salts or esters of such nucleoside dimers. Pharmaceutical compositions containing the dimers and methods of treatment utilizing the same are disclosed....	02/16/1993

PatentStorm

Did You Know...

PatentStorm News

Assignee: Baker Norton Pharmaceuticals, Inc.